Open Heart

DECEMBER 7, 2023

Objective This study aimed to investigate the association between heart failure (HF) severity measured based on brain natriuretic peptide (BNP) levels and future bleeding events after percutaneous coronary intervention (PCI).

Heart Failure 98

Heart Failure Academic Risk Factors Hospital 98

Frontiers in Cardiovascular Medicine

JANUARY 10, 2024

Ischemic heart disease (IHD) is one of the world's foremost killers, accounting for 16% of all deaths worldwide. IHD is the main cause of heart failure (HF), as it leads to pathological changes in the heart, improper pumping function and eventual death.

Heart Failure 59

Heart Failure Academic COVID-19 Innovation 59

DAIC

FEBRUARY 20, 2024

The expertise of our clinicians, like Dr. Saybolt, enables our academic medical center to provide these leading-edge clinical trials. Our program continues to grow as more of our neighbors select the academic medical center to receive exemplary health care,” said Kenneth N.

Heart Valves 116

Heart Valves Bicuspid/Mitral Academic Chest Pain 116

DAIC

APRIL 9, 2024

David Austin, MD “We did not see evidence that we could reduce this biomarker of cardiotoxicity during chemotherapy [with an ACE inhibitor],” said David Austin, MD , consultant cardiologist at the academic cardiovascular unit in James Cook University Hospital , South Tees, Middlesbrough, United Kingdom, and the study’s lead author.

ACE Inhibitor 105

ACE Inhibitor Cancer Biomarkers Heart Failure 105

DAIC

JUNE 3, 2024

Stone , Director of Academic Affairs for the Mount Sinai Health System and Professor of Medicine (Cardiology), and Population Health Science and Policy, at the Icahn School of Medicine at Mount Sinai (New York, USA) will be the Principal Investigator of the Pivotal study.

Bicuspid/Mitral 105

Bicuspid/Mitral Technology Open-Heart Surgery Innovation 105

DAIC

AUGUST 27, 2024

We know that structural heart disease and heart failure are the leading causes of hospitalization and morbidity in the U.S. CARDIO was trained on hundreds of thousands of studies comprising over 24 million echo video clips.

Ultrasound 98

Ultrasound Tricuspid Bicuspid/Mitral Aortic 98

CardiacWire

JUNE 21, 2024

The researchers set out to solve this problem using AI, and indeed showed that AI could perform MR exams at the same level as academic echo labs. Transthoracic echocardiography is the go-to modality for mitral regurgitation diagnosis, but these exams are difficult to perform and prone to high variability.

Bicuspid/Mitral 59

Bicuspid/Mitral Research Academic Heart Failure 59

DAIC

DECEMBER 18, 2024

In fact, 25 percent of cardiac patients over 80 will likely have a form of amyloidosis in their hearts; 13 percent of patients with heart failure have amyloid proteins in their systems and 3.5 Without proper care the average life expectancies for AL amyloidosis and ATTR amyloidosis patients are 6 months and 2.6

Cardiomyopathy 52

Cardiomyopathy Academic Heart Failure Cardiovascular Disease 52

Clinical Trial Results

NOVEMBER 18, 2024

During conduct of the REALIZE-K Trial, Dr. Mikhail Kosiborod acted as the PI from an independent academic research organization; he was not an employee of AstraZeneca during the design or conduct of REALIZE-K Trial or at the time of manuscript submission.

Download 40

Download Academic Heart Failure Research 40

Dr. S. Venkatesan MD

OCTOBER 26, 2024

There is less compelling academic reasons for this change, than we think. It is worth-while to wait, watch and think before we adopt this modality for mass consumption in heart failure with wide qrs LBBB.

Cardiomyopathy 40

Cardiomyopathy Bradycardia Academic Transplant 40

Dr. Anish Koka

FEBRUARY 6, 2023

So imagine my surprise when I saw peer reviewed research based on a cardiac MRI study come out in 2020 suggesting that 78% of patients who survived COVID may have significant heart damage. The article and authors were more suited as writers for Oprah and Dr. Phil than a well respected academic journal. I have no idea.

COVID-19 52

COVID-19 Chest Pain Academic Hospital 52

Dr. Smith's ECG Blog

OCTOBER 18, 2023

NT-pro-BNP peaked at 4831, consistent with heart failure. This distinction is more than academic — because both treatment and the response to therapy tend to be different with these 2 entities. The patient was referred for coronary angiography which did not reveal any atherosclerotic changes. Troponin I peaked at 769 ng/L.

Cardiac Arrest 117

Cardiac Arrest Tachycardia Cardiomyopathy Bradycardia 117

Dr. Anish Koka

JANUARY 18, 2023

The open-data movement seeks to liberate the massive amount of data generated in running clinical trials from the grasp of the academic medical-pharmaceutical industrial complex that mostly runs the most important trials responsible for bringing novel therapeutics to market. But first, some background.

Document 52

Document Academic Heart Attack Heart attacks 52

Cardiology Update

APRIL 9, 2024

Investigators assessed if empagliflozin could lower the risk of hospitalization for heart failure (HF) or death from cardiovascular disease (CVD). The primary superiority endpoint was clinically relevant bleeding (Bleeding Academic Research Consortium [known as BARC] types 2, 3, or 5).

Myocardial Infarction 52

Myocardial Infarction Angina Aortic valve Coronary Artery Disease 52

EMS 12-Lead

MARCH 19, 2023

He denied any known medical history, specifically: coronary artery disease, hypertension, dyslipidemia, diabetes, heart failure, myocardial infarction, or any prior PCI/stent. Breath sounds were clear in all lung fields. No appreciable skin pallor. He reported to be a social drinker, but used tobacco products daily.

Myocardial Infarction 52

Myocardial Infarction STEMI Coronary Angiogram Coronary Artery Disease 52

Dr. Smith's ECG Blog

OCTOBER 6, 2023

This is one case where it made a difference: Right Ventricular MI seen on ECG helps Angiographer to find Culprit Lesion Nevertheless, it is sometimes a fun academic exercise to try to predict the infarct artery: An elderly patient had onset of chest pain one hour prior. He called 911. Here is the prehospital ECG. What do you think?

Aneurysm 71

Aneurysm Chest Pain Cardiogenic Shock Blog 71

Dr. Anish Koka

FEBRUARY 13, 2023

More evidence this past week that vaccine myocarditis is very much a real entity while COVID19 myocarditis is mostly a fabrication of academic researchers comes from Scandinavian countries. Subscribe for free to receive new posts and support my work. Notice that there is no spike in myocarditis diagnoses until the second half of 2021.

COVID-19 52

COVID-19 Public Health Pediatrics Chest Pain 52

Cardiometabolic Health Congress

MARCH 8, 2024

Anuradha Lala-Trindade, MD: She focuses on the selection and care of patients with mechanical circulatory support devices and heart transplantation, genetic cardiomyopathies, and perioperative management of high-risk cardiac surgical cases. A framework for mentor-mentees can help promote and retain women in academic medicine.

Cardiac Rehabilitation 59

Cardiac Rehabilitation Academic Diabetes Research 59

Dr. Anish Koka

DECEMBER 12, 2022

It is interesting particularly because the ensconced narrative in academic circles and the medically related twitterati that seem to have an outsized influence on COVID related policy has been that vaccine myocarditis is “mild” Leo Lam, Ph.D.💉⚕️🌎🇺🇸🇬🇧🏴󠁧󠁢󠁳󠁣󠁴󠁿🇭🇰

Sudden Cardiac Death 52

Sudden Cardiac Death Chest Pain Hospital Heart Failure 52

Dr. Malcolm Kendrick

OCTOBER 30, 2024

At one point George Mann attempted to arrange a meeting of scientists who agreed that the diet-heart/cholesterol hypothesis was bunk. I believe you are right, and that the diet-heart hypothesis is wrong, but I cannot join you, for that would jeopardize my perks and funding. SEARCH trial of simvastatin dose (1997-2010) Merck: £22.7M

Cholesterol 145

Cholesterol Article Research Diet 145

Dr. Smith's ECG Blog

APRIL 8, 2015

History of Cardiovascular disease (all studies): Especially any history of heart failure or structural cardiac disease, including valvular 4. Academic Emergency Medicine., h/o heart disease (+1) 3. Academic Emergency Medicine, 2003 Volume 10, Number 5 539-540. Age greater than 65 (Sarasin and STePS) 3. Mukarram, M.,

Arrhythmia 52

Arrhythmia Outcomes Risk Factors Chest Pain 52